Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pepin

Showing results (1341-1350 of 1,433) with videos related to

Pageof 144
Sort By:
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 8, 2022
Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort StudyValentine Lidou-Renault, Edouard Baudouin, Pauline Courtois-Amiot, et al.
Blood|March 21, 2014
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myelomaJoaquin Martinez-Lopez, Juan J Lahuerta, François Pepin, et al.
Gynecologic Oncology|February 14, 2026
Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO- E/GOG-3041/ENGOT-EN10 trialShannon N Westin, Kathleen Moore, Hye Sook Chon, et al.
Transboundary and Emerging Diseases|April 30, 2025
Landscape-Scale Epidemiological Dynamics of SARS-CoV-2 in White-Tailed DeerJoshua Hewitt, Grete Wilson-Henjum, Derek T Collins, et al.
BMC Cancer|July 2, 2025
Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO)Raphaël Leman, François Cherifi, Marianne Leheurteur, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2024
Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapyChristof Vulsteke, Setsuko K Chambers, Maria Jesús Rubio Pérez, et al.
Gynecologic Oncology|August 25, 2023
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancerSandro Pignata, Michael Bookman, Jalid Sehouli, et al.
JCI Insight|January 25, 2019
Resident macrophages reprogram toward a developmental state after acute kidney injuryJeremie M Lever, Travis D Hull, Ravindra Boddu, et al.
JBMR Plus|May 28, 2019
A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis ImperfectaJaskaran S Bains, Erin M Carter, Kate P Citron, et al.
Human Mutation|June 21, 2008
CRTAP and LEPRE1 mutations in recessive osteogenesis imperfectaDustin Baldridge, Ulrike Schwarze, Roy Morello, et al.
Pageof 144

Showing results (1341-1350 of 1,433) with videos related to

Sort By:
Pageof 144
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 8, 2022
Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort StudyValentine Lidou-Renault, Edouard Baudouin, Pauline Courtois-Amiot, et al.
Blood|March 21, 2014
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myelomaJoaquin Martinez-Lopez, Juan J Lahuerta, François Pepin, et al.
Gynecologic Oncology|February 14, 2026
Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO- E/GOG-3041/ENGOT-EN10 trialShannon N Westin, Kathleen Moore, Hye Sook Chon, et al.
Transboundary and Emerging Diseases|April 30, 2025
Landscape-Scale Epidemiological Dynamics of SARS-CoV-2 in White-Tailed DeerJoshua Hewitt, Grete Wilson-Henjum, Derek T Collins, et al.
BMC Cancer|July 2, 2025
Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO)Raphaël Leman, François Cherifi, Marianne Leheurteur, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2024
Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapyChristof Vulsteke, Setsuko K Chambers, Maria Jesús Rubio Pérez, et al.
Gynecologic Oncology|August 25, 2023
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancerSandro Pignata, Michael Bookman, Jalid Sehouli, et al.
JCI Insight|January 25, 2019
Resident macrophages reprogram toward a developmental state after acute kidney injuryJeremie M Lever, Travis D Hull, Ravindra Boddu, et al.
JBMR Plus|May 28, 2019
A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis ImperfectaJaskaran S Bains, Erin M Carter, Kate P Citron, et al.
Human Mutation|June 21, 2008
CRTAP and LEPRE1 mutations in recessive osteogenesis imperfectaDustin Baldridge, Ulrike Schwarze, Roy Morello, et al.
Pageof 144